Follicular stimulating hormone enhances Notch 1 expression in SK-OV-3 ovarian cancer cells

Journal of Gynecologic Oncology

Volumn 21, Issue 2, 2010, Pages 119-124

  Park, Young Han ^a   Kim, Su Jin ^a   Jeong, Byung Hoon ^a   Herzog, Thomas J ^b   Wright, Jason ^b   Kitajewski, Jan ^b   Rhim, Chae Chun ^a   Jang, Pong Rheem ^a   Kang, Jung Bae ^a   Kim, Sung Ju ^a  

^a Hallym University   (South Korea)

^b Department of Medicine   (United States)

Author keywords

Follicular stimulating hormone; Notch 1; Ovarian cancer

Indexed keywords

FOLLITROPIN; NOTCH1 RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; OVARY CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 77954468403     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2010.21.2.119     Document Type: Article

References (16)

1. Berg JW, Lampe JG. High-risk factors in gynecologic cancer. Cancer 1981; 48: 429-41.
2. Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA, et al. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 2001; 128: 3675-83.
3. Esni F, Ghosh B, Biankin AV, Lin JW, Albert MA, Yu X, et al. Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development 2004; 131: 4213-24.
4. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005; 438: 946-53.
5. Fox KM, Dias JA, Van Roey P. Three-dimensional structure of human follicle-stimulating hormone. Mol Endocrinol 2001; 15: 378-89. (Pubitemid 32221915)
6. Monniaux D, Huet C, Besnard N, Clement F, Bosc M, Pisselet C, et al. Follicular growth and ovarian dynamics in mammals. J Reprod Fertil Suppl 1997; 51: 3-23.
7. van der Meer M, Hompes PG, Scheele F, Schoute E, Veersema S, Schoemaker J. Follicle stimulating hormone (FSH) dynamics of low dose step-up ovulation induction with FSH in patients with polycystic ovary syndrome. Hum Reprod 1994; 9: 1612-7. (Pubitemid 24291071)
8. Yoo HR, Yoon MK, Park YH, Park HR, Jang PR. The effects of gonadotropins on the development of ovarian cancer. Korean J Obstet Gynecol 2004; 47: 1698-705.
9. Simon WE, Albrecht M, Hansel M, Dietel M, Holzel F. Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J Natl Cancer Inst 1983; 70: 839-45. (Pubitemid 13101481)
10. Wimalasena J, Dostal R, Meehan D. Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth. Gynecol Oncol 1992; 46: 345-50.
11. Ji Q, Liu PI, Chen PK, Aoyama C. Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells. Int J Cancer 2004; 112: 803-14. (Pubitemid 39435265)
12. Hopfer O, Zwahlen D, Fey MF, Aebi S. The Notch pathway in ovarian carcinomas and adenomas. Br J Cancer 2005; 93: 709-18. (Pubitemid 41486463)
13. Zagouras P, Stifani S, Blaumueller CM, Carcangiu ML, Artavanis-Tsakonas S. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A 1995; 92: 6414-8.
14. Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, et al. High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 2005; 65: 8530-7.
15. Collins BJ, Kleeberger W, Ball DW. Notch in lung development and lung cancer. Semin Cancer Biol 2004; 14: 357-64.
16. Ellisen LW, Bird J, West DC, Soreng AL, Reynolds TC, Smith SD, et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 1991; 66: 649-61.